Skip to content

Comparing New Technologies and Expert Evaluation for Diagnosing Dry Eye Disease

Diagnostic Performance of Novel OSDx Device, OSA Plus System, and Clinical Expert in the Evaluation of Dry Eye Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092223
Enrollment
220
Registered
2025-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H188- Other specified disorders of cornea

Interventions

Intervention1: OSDx: Participants will undergo diagnostic evaluation using the OSDx device to assess its diagnostic performance for Dry Eye Disease (DED). The total duration of the intervention will b

Sponsors

Remidio Innovative Solutions Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Normals and dry eye subjects (based on OSDI score)

Exclusion criteria

Exclusion criteria: Subjects who are pregnant and nursing Subjects with recent eye surgery or trauma Individuals with uncontrolled systemic diseases such as diabetes autoimmune disorders or Sjogrens syndrome which can contribute to dry eye Subject with ocular diseases such as Glaucoma Diabetic Retinopathy Cataract ARMD Uveitis infections and inflammation Subjects undertaking medication like Antihistamines Beta-blockers Antidepressants or other Glaucoma medications for example prostaglandin analogs which may affect tear film structure or quality

Design outcomes

Primary

MeasureTime frame
Definition: Diagnostic accuracy of OSDx compared to Clinical expert and predicate device (OSA plus) Measurement: Sensitivity, specificity, positive and negative predictive valuesTimepoint: At the time of a single clinical visit (Day 0); repeat testing in 20% of participants within 1 7 days to assess test retest reliability

Secondary

MeasureTime frame
Correlation of OSDx & predicate device parameters (TMH, MG loss %, blink rate analysis, & Lipid Layer Thickness). Differences in diagnostic parameters between OSDx & predicate device (e.g., mean TM ROC, MGD, etc.). Agreement between device-based diagnoses (OSDx & predicate device) & clinical expert diagnosis. Classification performance of the OSDx & predicate devices in subgroups of dry eye severity. Inter & Intra observer repeatability in subset of participants for OSDx device.Timepoint: Repeat testing within 1 7 days from initial visit (only in 20% subset) rest everything will be done at the time of single diagnostic visit (Day 0)

Countries

India

Contacts

Public ContactRanjitha K

Dr Shroffs Charity Eye Hospital

ramkailash.gujar@sceh.net9818306116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026